Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
NIR-Responsive Silicon-Rhodamine Based Photosensitizer: A Promising Approach For Glioblastoma Treatment
Download
Naz Özoğul_master thesis.pdf
Naz Özoğul.pdf
Date
2025-4
Author
Özoğul, Naz
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
734
views
0
downloads
Cite This
Glioblastoma multiforme (GBM) is a highly lethal brain cancer with poor prognosis due to its aggressive and heterogeneous nature. Photodynamic therapy (PDT) has emerged as a promising alternative for GBM treatment. In this study, we present SiCNBr, a novel silicon-rhodamine-based photosensitizer synthesized and characterized for the first time and evaluate its anticancer potential under near-infrared (NIR) light activation. Cytotoxicity assays were performed on genetically distinct glioblastoma cell lines (U-87 MG, T98 G, U-118 MG) and a healthy fibroblast line (L929). While SiCNBr showed no dark toxicity, it induced significant phototoxicity in U-87 MG cells, with the lowest IC₅₀ value determined as 3.04 µM. No significant effect was observed in T98 G and U-118 MG cells. The compound also exhibited phototoxicity in the healthy L929 line, guiding subsequent experiments to focus on U-87 MG cells. To elucidate the mechanism of action, ROS scavenger assays were conducted, revealing a predominant increase in general ROS levels and a partial contribution from singlet oxygen. These findings were further supported by confocal fluorescence imaging, which confirmed intracellular ROS accumulation. Subcellular localization studies showed that SiCNBr accumulates primarily in mitochondria, with partial lysosomal presence. Importantly, due to its fluorescent properties and compatibility with confocal imaging, SiCNBr also functions as a theranostic agent—offering both therapeutic efficacy and diagnostic traceability. These results collectively demonstrate that SiCNBr is a potent and selectively phototoxic agent in GBM and holds promise for further development as a dual-purpose therapeutic and diagnostic candidate.
Subject Keywords
Cancer
,
Glioblastoma Multiforme
,
Photodynamic Therapy
,
Photosensitizer
,
Near-IR activatable
URI
https://hdl.handle.net/11511/114933
Collections
Graduate School of Natural and Applied Sciences, Thesis
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
N. Özoğul, “NIR-Responsive Silicon-Rhodamine Based Photosensitizer: A Promising Approach For Glioblastoma Treatment,” M.S. - Master of Science, Middle East Technical University, 2025.